Allogeneic TRAC Locus-inserted CD19-targeting Synthetic T-cell Receptor Antigen Receptor (STAR) T Cells for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Latest Information Update: 28 Mar 2024
At a glance
- Drugs CD19 TCR T cell therapy China Immunotech (Primary) ; Cyclophosphamide (Primary) ; Fludarabine (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma; Marginal zone B-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 24 Mar 2024 New trial record